Stock Ratings from Analyst Ratings Network

Open Main Menu Open Sidebar

Sunesis Pharmaceuticals Company Profile (NASDAQ:SNSS)

Consensus Ratings for Sunesis Pharmaceuticals (NASDAQ:SNSS) (?)
Ratings Breakdown: 1 Sell Rating(s), 1 Hold Rating(s), 2 Buy Rating(s)
Consensus Rating:Hold (Score: 2.25)
Consensus Price Target: $12.13 (107.41% upside)

Analysts' Ratings History for Sunesis Pharmaceuticals (NASDAQ:SNSS)
Show:
DateFirmActionRatingPrice TargetDetailsShare
5/9/2014TheStreetDowngradeHold -> SellViewTweet This Rating  Share This Rating on StockTwits
3/10/2014Cantor FitzgeraldBoost Price Target$8.00 -> $14.00ViewTweet This Rating  Share This Rating on StockTwits
3/5/2014Leerink SwannBoost Price TargetOutperform$14.00 -> $17.00ViewTweet This Rating  Share This Rating on StockTwits
2/25/2014Leerink SwannBoost Price Target$10.00 -> $14.00ViewTweet This Rating  Share This Rating on StockTwits
1/20/2014ZacksUpgradeNeutral -> Outperform$5.40ViewTweet This Rating  Share This Rating on StockTwits
7/31/2013Credit SuisseDowngradeNeutralViewTweet This Rating  Share This Rating on StockTwits
1/15/2013Credit SuisseInitiated CoverageOutperform$7.00ViewTweet This Rating  Share This Rating on StockTwits
12/19/2012Wells Fargo & Co.Initiated CoverageOutperformViewTweet This Rating  Share This Rating on StockTwits
10/5/2012Cowen and CompanyReiterated RatingOutperformViewTweet This Rating  Share This Rating on StockTwits
9/21/2012Cowen and CompanyReiterated RatingOutperformViewTweet This Rating  Share This Rating on StockTwits
9/11/2012WedbushReiterated RatingOutperformViewTweet This Rating  Share This Rating on StockTwits
9/11/2012Cantor FitzgeraldReiterated RatingBuy$6.00 -> $8.00ViewTweet This Rating  Share This Rating on StockTwits
9/5/2012Leerink SwannInitiated CoverageOutperformViewTweet This Rating  Share This Rating on StockTwits
(Data available from 7/23/2012 forward)